Item 8.01. Other Events.
On April 5, 2023, 9 Meters Biopharma, Inc. issued a press release announcing
receipt of a written response from the U.S. Food and Drug Administration on the
request for a Type B pre-IND (Investigational New Drug) meeting on the planned
pre-clinical development of NM-136 for the treatment of obesity. A copy of the
press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
Exhibit 99.1 Press Release dated April 5, 2023.
Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
© Edgar Online, source Glimpses